Clinical Trials Logo

Urinary Incontinence clinical trials

View clinical trials related to Urinary Incontinence.

Filter by:
  • Terminated  
  • Page 1 ·  Next »

NCT ID: NCT05458375 Terminated - Clinical trials for Urinary Incontinence

Vaginal Estradiol Use in Pessary Care

Start date: December 29, 2022
Phase: Early Phase 1
Study type: Interventional

The primary outcome of this study compare the rate of pessary discontinuation at 6 months post-pessary fitting in women using vaginal estradiol versus those not using vaginal estradiol.

NCT ID: NCT05128682 Terminated - Clinical trials for Urinary Incontinence

Acute Pudendal Nerve Stimulation On Leak Point Pressure In Women Urodynamic Early Feasibility Study

PNS_UDT
Start date: May 24, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is tp evaluate the changes in stress induced Urethral Leak Point Pressures (LPP) and other urodynamic measurements in response to acute pudendal nerve stimulation (PNS) in patients with a pre-existing implanted urological neurostimulator stimulating the pudendal nerve.

NCT ID: NCT05072158 Terminated - Clinical trials for Urinary Incontinence

Pelvic Floor Disorders Among Sexual Minoritized Women

PRIDE
Start date: October 14, 2021
Phase:
Study type: Observational

The investigators aim to perform cognitive interviews to assess how pelvic floor disorders impact sexual functioning in women who have sex with women (WSW). As a secondary objective there will be cognitive interviews to assess perceptions of sexual function questionnaires such as Female Sexual Function Index (FSFI) and Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-IUGA Revised (PISQ-IR) in WSW.

NCT ID: NCT04420585 Terminated - Anemia, Sickle Cell Clinical Trials

Desmopressin for Bedwetting in Children With SCD

Start date: July 7, 2020
Phase: Phase 4
Study type: Interventional

This study assesses if using the medication desmopressin will decrease nightime bedwetting in children with sickle cell disease.

NCT ID: NCT04305379 Terminated - Prostate Cancer Clinical Trials

Augmented BLAdder NecK rEconstruction Trial for Improved Urinary Function After Radical Prostatectomy

BLANKET
Start date: January 16, 2020
Phase: N/A
Study type: Interventional

The investigators are conducting a prospective, randomized trial to investigate whether patients randomized to receive an augmented bladder neck reconstruction (aBNR) at the time of robotic-assisted laparoscopic prostatectomy experience improved urinary function post-operatively compared to patients who undergo prostatectomy with a standard BNR. An aBNR here consists of the autologous medial umbilical ligament sling as well as a bladder neck intussusception stitch. The standard BNR group will receive the intussusception stitch only.

NCT ID: NCT04122898 Terminated - Clinical trials for Urinary Incontinence

Pelvic Floor Muscle Training in Gymnasts With Stress Urinary Incontinence

Start date: January 20, 2020
Phase: N/A
Study type: Interventional

There is a high prevalence of urinary incontinence (UI) among female athletes participating in high impact sports, such as artistic gymnastics, trampoline jumping and ball games. UI is defined as "the complaint of involuntary loss of urine". Stress urinary incontinence (SUI) is the most common type of UI and is defined as "the complaint of involuntary loss of urine on effort or physical exertion (e.g. sporting activities), or or sneezing or coughing". Urinary leakage during sport activities may affect the athletes' performance, cause bother, frustration and embarrassment and furthermore lead to avoidance and cessation of sport activities. Pelvic floor muscle (PFM) training is highly effective in treating SUI in the general female population. However, evidence of the effect of PFM training in elite athletes in high impact sports is sparse. The purpose of this assessor-blinded randomized controlled trial (RCT) is to assess the effect of PFM training on symptoms, bother and amount of SUI in female artistic gymnasts, team gymnasts and cheerleaders.

NCT ID: NCT04059653 Terminated - Clinical trials for Urinary Incontinence

Evaluation of a New Technology for the Treatment of Bladder Leakage in Women

Start date: January 6, 2020
Phase: N/A
Study type: Interventional

Evaluation of a new technology for the treatment of bladder leakage in women. The objective is to compare quality of life and other incontinence associated outcomes between women receiving routine General Practitioner (GP) prescribed care for urinary incontinence compared with those prescribed the electrical stimulation device.

NCT ID: NCT04026347 Terminated - Clinical trials for Stress Urinary Incontinence

Vesair Clinical Trial

VAPOR
Start date: February 1, 2020
Phase: N/A
Study type: Interventional

Single-blind, multicenter, randomized clinical trial of the Vesair Balloon in the treatment of Stress Urinary Incontinence in post-menopausal women

NCT ID: NCT03923348 Terminated - Overactive Bladder Clinical Trials

Pelvic Floor Muscle Training With Leva System for Urge Incontinence

Start date: June 6, 2019
Phase: N/A
Study type: Interventional

This is a pilot non-comparative study to assess the effectiveness of pelvic floor muscle training guided by the leva® system for improving change in subject-reported incontinence-related quality of life and urgency urinary incontinence (UUI) episode frequency based on voiding diaries in women at 8 weeks.

NCT ID: NCT03849365 Terminated - Clinical trials for Low Risk Prostate Cancer

Study of Erectile Dysfunction, Urinary Incontinence and Related QoL After TOOKAD® VTP for Low Risk Prostate Cancer

Start date: January 21, 2019
Phase: Phase 4
Study type: Interventional

Multiple center, single-arm, open-label, 12-month follow-up phase IV pragmatic clinical trial in men with unilateral prostate cancer meeting eligibility criteria for the drug (as per the European Economic Area (EEA) Marketing Authorisation) to assess the occurrence and dynamics of the time with toxicities (urinary incontinence Grade 2 and over and/or erectile dysfunction Grade 2 and over) in patients 12 months following TOOKAD® VTP.